• ქართული
  • English
  • Japan's Takeda gains U.S. approval for $62 billion Shire buy

    Takeda Pharmaceutical Co Ltd on Tuesday said it has received U.S. approval for its $62 billion acquisition of London-listed Shire Plc, taking the Japanese firm one step closer to its goal of becoming a global top 10 drugmaker.

    Market Quotes by TradingView